£103.26

Humana Multiple Sclerosis: Etiology, Diagnosis, and New Treatment Strategies (Current Clinical Neurology)

Price data last checked 18 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 2 months ago.

£103 today · all-time low £103 (May 2026) · usually £103

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 73 days · 73 data points (no recent data)

Historical
Generating forecast…
£108.00 £102.76 £103.91 £105.05 £106.19 £107.33 £108.48 25 April 2026 13 May 2026 31 May 2026 18 June 2026 06 July 2026

Price Distribution

Price distribution over 73 days • 2 price levels

Days at Price
Current Price
67 days · current 6 days 0 17 34 50 67 £103 £108 Days at Price

Price Analysis

Most common price: £103 (67 days, 91.8%)

Price range: £103 - £108

Price levels: 2 different prices over 73 days

Description

A synthesis of current concepts about the evaluation, treatment, and future directions in MS. On the evaluation side, the authors review the use of MRI, magnetic resonance spectroscopy, functional MRI, and three-dimensional MRI, and consider the rapidly developing body of pathologic information they have yielded. On the treatment side, the focus is on recently approved medications (Novantrone), new indications for medications (CHAMPS Trial), medications in development (Oral Interferon Tau, Oral Copaxone, and Oral Cellcept), immunosuppressive therapy for both progressive disease and symptomatic therapy; the current medications for treating relapsing-remitting MS (Avonex, Betaseron, and Copaxone) are also discussed. For future directions, the authors present the current best thinking, as well as the latest discoveries in immunology relating to MS, including groundbreaking B-cell research and its applications to specific immunotherapies, and the use of immune markers for tracking the disease. Review From the reviews: "...offers a practical, management-oriented approach to MS and interpretation of current clinical literature. Unique to this publication is the review of pregnancy and cognitive issues." - Doody's Health Sciences Book Review Journal "To provide current concepts, approaches to management, and future directions in multiple sclerosis research. …This multiauthored text contains chapters covering clinical features, investigations, underlying mechanisms, and approaches to treatment of multiple sclerosis, with an attempt to outline future directions. … The views and discussions in the book are fresh and up-to-date. … Olek, summarizes the differential diagnosis, clinical features, and prognosis of multiple sclerosis and is the strongest and most important … for general physicians." (Jock T. Murray, Annals of Internal Medicine, Vol. 142 (9), 2005) "This multiauthor book consists of a series of 12 monographs on the various clinical aspects of multiple sclerosis and, as such, is aimed primarily at the general physician … . it is a well-written text and neuroradiologists with a specific interest in multiple sclerosis will find the wealth of discussion on the current and future treatment strategies of the disease useful. … This text might be more useful to junior medical staff starting research projects in the area of multiple sclerosis … ." (Amlyn L. Evans and Daniel J. A. Connolly, Neuroradiology, Vol. 46, 2006) From the Back Cover The recent explosion of new information about the pathology, pathophysiology, clinical classification, imaging, and treatment of multiple sclerosis (MS) has dramatically opened the way to a deeper understanding of the disease and a more effective therapeutic landscape for patients. In Multiple Sclerosis: Etiology, Diagnosis, and New Treatment Strategies, leading MS physicians synthesize current concepts about the evaluation, treatment, and future directions in MS. On the evaluation side, the authors review the use of magnetic resonance imaging (MRI), magnetic resonance spectroscopy, functional MRI, and three-dimensional MRI, and consider the rapidly developing body of pathologic information they have yielded. On the treatment side, the focus is on recently approved medications (Novantrone), new indications for medications (CHAMPS Trial), medications in development (Oral Interferon Tau, Oral Copaxone, and Oral Cellcept), immunosuppressive therapy for both progressive disease and symptomatic therapy; the current medications for treating relapsing-remitting MS (Avonex, Betaseron, and Copaxone) are also discussed. For future directions, the authors present the current best thinking, as well as the latest discoveries in immunology relating to MS, including groundbreaking B-cell research, its applications to specific immunotherapies, and the use of immune markers for tracking the disease. Additional chapters cover the mechanism and application of myelin rep

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Multiple Sclerosis: A Mechanistic View
98% match

Multiple Sclerosis: A Mechanistic View

Academic Press

£95.00 08 Jul 2026
McAlpine's Multiple Sclerosis
98% match

McAlpine's Multiple Sclerosis

Elsevier

£212.99 20 Jun 2026
Translational Neuroimmunology in Multiple Sclerosis: From Disease Mechanisms to Clinical Applications
98% match

Translational Neuroimmunology in Multiple Sclerosis: From Disease Mechanisms to Clinical Applications

Academic Press

£79.88 15 Jul 2026
Multiple Sclerosis and CNS Inflammatory Disorders (NIP- Neurology in Practice)
97% match

Multiple Sclerosis and CNS Inflammatory Disorders (NIP- Neurology in Practice)

Wiley

£63.99 02 Jul 2026
International Review of Neurobiology,79: Volume 79
97% match

International Review of Neurobiology,79: Volume 79

Academic Press

£120.36 11 Jul 2026
Multiple Sclerosis, An Issue of Neurologic Clinics: Volume 42-1 (The Clinics: Internal Medicine, Volume 42-1)
97% match

Multiple Sclerosis, An Issue of Neurologic Clinics: Volume 42-1 (The Clinics: Internal Medicine, Volume 42-1)

Elsevier

£65.98 02 Jul 2026
Handbook of Multiple Sclerosis
97% match

Handbook of Multiple Sclerosis

Foster Academics

£73.36 04 Jul 2026
Multiple Sclerosis: Causes, Diagnosis & Management (Immunology and Immune System Disorders)
97% match

Multiple Sclerosis: Causes, Diagnosis & Management (Immunology and Immune System Disorders)

£133.99 09 Jul 2026
Mechanisms of Disease Pathogenesis in Multiple Sclerosis
97% match

Mechanisms of Disease Pathogenesis in Multiple Sclerosis

Academic Press

£98.96 09 Jul 2026
Emerging and Evolving Topics in Multiple Sclerosis Pathogenesis and Treatments: 26 (Current Topics in Behavioral Neurosciences)
97% match

Emerging and Evolving Topics in Multiple Sclerosis Pathogenesis and Treatments: 26 (Current Topics in Behavioral Neurosciences)

Springer

£89.94 04 Jul 2026
Myelin Repair and Neuroprotection in Multiple Sclerosis
97% match

Myelin Repair and Neuroprotection in Multiple Sclerosis

Springer

£88.19 07 Jul 2026
Handbook of Imaging in Multiple Sclerosis
97% match

Handbook of Imaging in Multiple Sclerosis

Academic Press

£116.00 24 Jun 2026
Multiple Sclerosis Therapeutics
97% match

Multiple Sclerosis Therapeutics

Cambridge University Press

£41.49 29 Jun 2026
The Biology of Multiple Sclerosis (Cambridge Medicine (Hardcover))
97% match

The Biology of Multiple Sclerosis (Cambridge Medicine (Hardcover))

Cambridge University Press

£40.50 16 Jul 2026
Advances in Multiple Sclerosis and Experimental Demyelinating Diseases: 318 (Current Topics in Microbiology and Immunology, 318)
97% match

Advances in Multiple Sclerosis and Experimental Demyelinating Diseases: 318 (Current Topics in Microbiology and Immunology, 318)

Springer

£108.00 13 Jul 2026
Progressive Multiple Sclerosis
97% match

Progressive Multiple Sclerosis

Springer

£144.00 15 Jul 2026
Multiple Sclerosis: Methods and Protocols: 1304 (Methods in Molecular Biology, 1304)
97% match

Multiple Sclerosis: Methods and Protocols: 1304 (Methods in Molecular Biology, 1304)

Humana

£77.05 09 Jul 2026
Multiple Sclerosis, An Issue of Neurologic Clinics (Volume 36-1) (The Clinics: Radiology, Volume 36-1)
97% match

Multiple Sclerosis, An Issue of Neurologic Clinics (Volume 36-1) (The Clinics: Radiology, Volume 36-1)

Elsevier

£62.87 15 Jul 2026
Multiple Sclerosis: Theory and Practice for Nurses
97% match

Multiple Sclerosis: Theory and Practice for Nurses

Wiley

£54.99 15 Jul 2026
Multiple Sclerosis: A Practical Manual for Hospital and Outpatient Care (Cambridge Manuals in Neurology)
97% match

Multiple Sclerosis: A Practical Manual for Hospital and Outpatient Care (Cambridge Manuals in Neurology)

Cambridge University Press

£40.94 08 Jul 2026
Multiple Sclerosis: Clinician's Guide To Diagnosis And Treatment (Oxford American Neurology Library)
97% match

Multiple Sclerosis: Clinician's Guide To Diagnosis And Treatment (Oxford American Neurology Library)

Oxford University Press

£31.13 11 Jul 2026
Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders (Current Clinical Neurology)
97% match

Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders (Current Clinical Neurology)

Humana

£66.74 20 Jun 2026
Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders (Current Clinical Neurology)
97% match

Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders (Current Clinical Neurology)

Humana

£89.37 08 Jul 2026
Multiple Sclerosis As A Neuronal Disease
96% match

Multiple Sclerosis As A Neuronal Disease

Academic Press

£67.93 26 Jun 2026